---
document_datetime: 2023-09-21 19:19:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rapamune-epar-all-authorised-presentations_en.pdf
document_name: rapamune-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1614691
conversion_datetime: 2025-12-28 11:20:25.945312
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                  | Content   | Package size                                                 |
|-----------------|-----------------|------------|-----------------------|---------------------------|----------------------------|-----------|--------------------------------------------------------------|
| EU/1/01/171/001 | Rapamune        | 1 mg/ml    | Oral solution         | Oral use                  | bottle (glass)             | 60 ml     | 1 bottle + 30 syringes + 1 syringe adapter + 1 carrying case |
| EU/1/01/171/007 | Rapamune        | 1 mg       | Coated tablet         | Oral use                  | blister (PVC/PE/aclar/alu) |           | 30 tablets                                                   |
| EU/1/01/171/008 | Rapamune        | 1 mg       | Coated tablet         | Oral use                  | blister (PVC/PE/aclar/alu) |           | 100 tablets                                                  |
| EU/1/01/171/009 | Rapamune        | 2 mg       | Coated tablet         | Oral use                  | blister (PVC/PE/Aclar/alu) |           | 30 tablets                                                   |
| EU/1/01/171/010 | Rapamune        | 2 mg       | Coated tablet         | Oral use                  | blister (PVC/PE/Aclar/alu) |           | 100 tablets                                                  |
| EU/1/01/171/013 | Rapamune        | 0.5 mg     | Coated tablet         | Oral use                  | blister (PVC/PE/aclar/alu) |           | 30 tablets                                                   |
| EU/1/01/171/014 | Rapamune        | 0.5 mg     | Coated tablet         | Oral use                  | blister (PVC/PE/aclar/alu) |           | 100 tablets                                                  |